• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Status of adverse drug reaction monitoring and pharmacovigilance in selected countries.

作者信息

Yadav Sachdev

机构信息

Department of Pharmacology, Rajiv Academy for Pharmacy, Mathura, Delhi-Mathura Highway, Chhattikara - 281 006, India.

出版信息

Indian J Pharmacol. 2008 Feb;40(Suppl 1):S4-9.

PMID:21369413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3038524/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/3038524/43442cd015b1/IJPharm-40-4-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/3038524/b557aa488bbd/IJPharm-40-4-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/3038524/43442cd015b1/IJPharm-40-4-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/3038524/b557aa488bbd/IJPharm-40-4-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e3a/3038524/43442cd015b1/IJPharm-40-4-g003.jpg

相似文献

1
Status of adverse drug reaction monitoring and pharmacovigilance in selected countries.部分国家药品不良反应监测与药物警戒的现状
Indian J Pharmacol. 2008 Feb;40(Suppl 1):S4-9.
2
Pharmacovigilance in developing countries (part I): importance and challenges.发展中国家的药物警戒（第一部分）：重要性与挑战
Int J Clin Pharm. 2018 Aug;40(4):758-763. doi: 10.1007/s11096-017-0570-z.
3
Pharmacovigilance in developing countries (part II): a path forward.发展中国家的药物警戒（第二部分）：前进之路。
Int J Clin Pharm. 2018 Aug;40(4):764-768. doi: 10.1007/s11096-017-0588-2.
4
Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.发展中国家患者对药品不良反应报告的看法：来自加纳的案例研究
Drug Saf. 2017 Oct;40(10):911-921. doi: 10.1007/s40264-017-0563-9.
5
Pharmacovigilance in the Middle East: a survey of 13 arabic-speaking countries.中东药物警戒：对 13 个阿拉伯语国家的调查。
Drug Saf. 2013 Jan;36(1):25-30. doi: 10.1007/s40264-012-0001-y.
6
Pharmacovigilance of herbal medicines in Africa: Questionnaire study.非洲草药的药物警戒：问卷调查研究
J Ethnopharmacol. 2015 Aug 2;171:99-108. doi: 10.1016/j.jep.2015.05.033. Epub 2015 May 28.
7
Direct reporting of adverse drug reactions by healthcare consumers in Africa: a narrative review.非洲医疗消费者直接报告药物不良反应：叙事性综述。
Int J Clin Pharm. 2021 Feb;43(1):11-24. doi: 10.1007/s11096-020-01141-x. Epub 2020 Sep 9.
8
Adverse Drug Reaction (ADR) Monitoring at the Eastern Regional Pharmacovigilance Centre, Nepal.尼泊尔东部地区药物警戒中心的药品不良反应（ADR）监测
Kathmandu Univ Med J (KUMJ). 2017;15(60):296-300.
9
Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital.抗肿瘤药物强化安全监测项目：葡萄牙一家肿瘤医院的一项试点研究。
J Oncol Pharm Pract. 2020 Jan;26(1):133-140. doi: 10.1177/1078155219849277. Epub 2019 May 22.
10
Overview of Pharmacovigilance System in Vietnam: Lessons Learned in a Resource-Restricted Country.越南药物警戒体系概述：资源有限国家的经验教训。
Drug Saf. 2018 Feb;41(2):151-159. doi: 10.1007/s40264-017-0598-y.

引用本文的文献

1
Adverse-drug reaction reporting by Pharm D students during hospital training.药学博士学生在医院培训期间的药品不良反应报告
Saudi Pharm J. 2023 Jul;31(7):1149-1156. doi: 10.1016/j.jsps.2023.05.012. Epub 2023 May 18.
2
A Data-Driven Reference Standard for Adverse Drug Reaction (RS-ADR) Signal Assessment: Development and Validation.基于数据的药物不良反应（RS-ADR）信号评估参考标准：制定与验证。
J Med Internet Res. 2022 Oct 6;24(10):e35464. doi: 10.2196/35464.
3
Physicians' Understanding and Practices of Pharmacovigilance: Qualitative Experience from A Lower Middle-Income Country.
医生对药物警戒的理解和实践：来自一个中下等收入国家的定性经验。
Int J Environ Res Public Health. 2020 Mar 25;17(7):2209. doi: 10.3390/ijerph17072209.
4
Good Pharmacovigilance Practice: Accountability of Ayurvedic Pharmaceutical Companies.良好药物警戒规范：阿育吠陀制药公司的责任
Anc Sci Life. 2017 Jan-Mar;36(3):167-169. doi: 10.4103/asl.ASL_10_17.
5
A Prospective Surveillance of Pharmacovigilance of Psychotropic Medicines in a Developing Country.发展中国家精神药物药物警戒的前瞻性监测
Psychopharmacol Bull. 2016 Mar 1;46(1):54-66.
6
Governance and pharmacovigilance in Brazil: a scoping review.巴西的治理与药物警戒：一项范围界定综述
J Pharm Policy Pract. 2016 Feb 8;9:3. doi: 10.1186/s40545-016-0053-y. eCollection 2016.
7
Good pharmacovigilance practice: Need of the hour from pharmaceutical companies.良好的药物警戒规范：制药公司当下的需求
Perspect Clin Res. 2015 Jul-Sep;6(3):171-2. doi: 10.4103/2229-3485.159944.
8
Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process.药剂师对药物警戒及药品不良反应报告流程的知识、实践与态度。
Saudi Pharm J. 2015 Apr;23(2):147-53. doi: 10.1016/j.jsps.2014.07.001. Epub 2014 Jul 10.
9
Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance.药品不良反应监测：药物警戒的前景与迫在眉睫的挑战
Springerplus. 2014 Nov 26;3:695. doi: 10.1186/2193-1801-3-695. eCollection 2014.
10
Adverse drug reactions reporting culture in Pharmacovigilance Programme of India.印度药物警戒计划中的药品不良反应报告文化
Indian J Med Res. 2014 Oct;140(4):563-4.